Nuvation Bio Inc. (NUVB) stock
NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30107% above fair value
$3.90+0.06 (+1.56%)
Close on Nov 17, 2026Market cap $1.37BP/E –Yield –
Nuvation Bio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Nuvation Bio's price to book ratio was 5.9× on Nov 11, 2026, against 8.3× a year earlier. Over the last 5 years it ranged from 0.3× to 9.3×, with a median of 1.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.9× | −3.4 |
| 2025 | Dec 31, 2025 | 9.3× | +7.5 |
| 2024 | Dec 31, 2024 | 1.8× | +1.2 |
| 2023 | Dec 29, 2023 | 0.5× | −0.1 |
| 2022 | Dec 30, 2022 | 0.6× | −1.8 |
| 2021 | Dec 31, 2021 | 2.4× | – |
See a number that looks wrong?